希玛医疗年度报告 2025

2025ANNUAL REPORT年度報告 Contents 2Corporate information4Financial highlights5Chairman’s statement8Management discussion and analysis30Profile of directors, senior management and company secretary41Report of the directors79Corporate governance report97Independent auditor’s report106Consolidated statement of comprehensive income108Consolidated statement of financial position110Consolidated statement of changes in equity112Consolidated statement of cash flows114Notes to the consolidated financial statements252Financial information summary Corporate Information公司資料 BOARD OF DIRECTORS Executive Directors 202561202561 Dr. LAM Shun Chiu Dennis(Chairman and Chief Executive Officer)(resigned with effect from 1 June 2025)Ms. LI Xiaoting (appointed as Vice Chairman andChief Executive Officer with effect from 1 June 2025)Dr. LEE Yau Wing Vincent Independent Non-executive Directors 202561202561202561 Dr. Rex AUYEUNG Pak-kuen(appointed as Chairman with effect from 1 June 2025)Dr. KO Wing Man(appointed as independent non-executive Director andVice Chairman with effect from 1 June 2025)Mr. MA Andrew Chiu CheungMr. IP Shu Kwan St ephenMr. YIN KeMr. LI Ling Cheung Raymond(appointed with effect from 1 June 2025) BOARD COMMITTEES Audit Committee 202561202561 Mr. MA Andrew Chiu Cheung(Chairperson)Mr. IP Shu Kwan StephenMr. LI Ling Cheung Raymond(appointed with effect from 1 June 2025)Mr. YIN Ke (ceased to be member with effect from 1 June 2025) Remuneration Committee 202561202561202561202561 Mr. IP Shu Kwan Stephen(Chairperson)Mr. YIN Ke(appointed with effect from 1 June 2025)Mr. LI Ling Cheung Raymond(appointed with effect from 1 June 2025)Ms. LI Xiaoting(ceased to be member with effect from 1 June 2025)Mr. MA Andrew Chiu Cheung(ceased to be member with effect from 1 June 2025) Nomination Committee 202561202561202561202561 Dr. Rex AUYEUNG Pak-kuen(Chairperson)Ms. LI Xiaoting(appointed with effect from 1 June 2025)Dr. KO Wing Man(appointed with effect from 1 June 2025)Mr. MA Andrew Chiu Cheung(ceased to be member with effect from 1 June 2025)Mr. YIN Ke (ceased to be member with effect from 1 June 2025) AUTHORIZED REPRESENTATIVES Ms. LI XiaotingMr. CHAN Wa Ping COMPANY SECRETARY AUDITOR 22 PricewaterhouseCoopersCertified Public AccountantsRegistered Public Interest Entity Auditor22/F, Prince’s BuildingCentralHong Kong REGISTERED OFFICE Cricket Square, Hutchins DriveP.O. Box 2681 Grand CaymanKY1-1111Cayman Islands Cricket Square, Hutchins DriveP.O. Box 2681 Grand CaymanKY1-1111Cayman Islands PRINCIPAL PLACE OF BUSINESS AND HEADOFFICE IN HONG KONG 1–31535 Suite 1535, Central Building1–3 Pedder StreetHong Kong PRINCIPAL SHARE REGISTRAR Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands HONG KONG BRANCH SHARE REGISTRAR 183171712–1716 Computershare Hong Kong Investor Services LimitedShops 1712–1716, 17th FloorHopewell Centre183 Queen’s Road EastWanchaiHong Kong PRINCIPAL BANKERS The Bank of East Asia, LimitedBank of China (Hong Kong) LimitedBank of Communications Co., Ltd.Industrial and Commercial Bank of China LimitedThe Hongkong and Shanghai Banking Corporation Limited LEGAL ADVISOR ON HONG KONG LAWS 8126 Fangda Partners26th Floor, One Exchange Square8 Connaught PlaceCentral, Hong Kong www.cmermedical.com COMPANY WEBSITE www.cmermedical.com 03309 STOCK CODE03309 Financial Highlights財務概要 2025123120241231 The board (the “Board”) of directors (the “Directors”) ofC-MER Medical Holdings Limited (the “Company”) reports theannual consolidated results of the Company and its subsidiaries(collectively, the “Group”) for the year ended 31 December 2025,together with the comparative figures for the year ended 31December 2024. 1.(1)(2) 1We define “adjusted gross profit for the year” as gross profit forthe year adjusted by (1) the impairment loss on non-current assetsand (2) gross loss from the Mainland China other business segment. 2.(1)(2) 2We define “adjusted profit for the year” as profit for the yearadjusted by (1) the impairment loss on non-current assets and (2)loss from the Mainland China other business segment. 3We define “adjusted profit for the year attributable to equityholders of the Company” as profit for the year attributable to equityholders of the Company adjusted by (1) the impairment loss onnon-current assets attributable to equity holders of the Company;and (2) the loss attributable to equity holders of the Company fromthe Mainland China other business segment. 3.(1)(2) Chairman’s Statement主席報告 20251231 On behalf of the Board, I am pleased to present to ourshareholders of the Company the annual report of the Group forthe year ended 31 December 2025. Our Group achieved a notable financial turnaround, movingfrom a loss in 2024 to a record high of the profit attributableto equity holders of